India TB Deaths Fall 38% Since 2015, WHO Finds

India's tuberculosis (TB) mortality rate has fallen by 38% since 2015, outpacing the global decline of 35%, according to the World Health Organization's Global Tuberculosis Report 2026, released on 12 November. The report also records a 94% treatment success rate among patients in India whose TB responds to standard medicines.
The estimated TB mortality rate in India fell from 28 deaths per lakh of population in 2015 to 18 per lakh in 2025, the Union health ministry said, citing the WHO report. The ministry's account was reported by Health and Family, while Asia Daily confirmed the same figures from the ministry's briefing.
One in four global cases still in India
The progress comes with a stark reminder of the scale of the challenge. India accounted for 25% of all people who developed TB worldwide in 2025, the largest share of any country. Globally, the WHO estimates that 10.6 million people developed TB and 1.13 million died from it in 2025, drawing on data from 187 countries and areas covering more than 99% of the world's population.
WHO Director-General Dr Tedros Adhanom Ghebreyesus welcomed the fall in illness and deaths while warning that the human cost remains high. "And yet, more than one million people still die each year from a disease that is preventable and treatable," he said in the WHO's statement on 12 November.
Screening drive reached 250 million people
India's gains are linked to a vast screening campaign under the TB Mukt Bharat Abhiyaan. Between 7 December 2024 and 8 November 2026, the campaign brought more than 250 million people into screening activities and identified 4.864 million TB cases, including 1.497 million people who had no symptoms. More than 110 million chest X-rays and about 30 million rapid molecular tests were carried out during the campaign, with portable AI-enabled digital X-rays helping to reach communities far from clinics.
The programme also leans on the Ni-kshay digital platform to track patients and treatment, and on nutritional support through the Ni-kshay Poshan Yojana, under which eligible patients receive financial help towards food during treatment. The health ministry said 96% of India's TB programme funding requirements are now met from domestic resources, and 67,933 village councils were declared TB-free in 2025.
Gaps remain in diagnosis
Despite the progress, the WHO report warns that the world is far from its elimination targets. An estimated 2.2 million people who developed TB in 2025 were never diagnosed or reported, roughly one in five cases, and only 59% of newly diagnosed patients received a rapid diagnostic test recommended by WHO. Drug-resistant TB also remains a serious problem: an estimated 370,000 people developed TB resistant to rifampicin, a major TB medicine, in 2025, and only 42% of them received treatment.
India's own incidence estimates are under review. The Indian Council of Medical Research's National Institute for Research in Tuberculosis conducted a nationally representative prevalence survey in 2025, and updated estimates of India's TB incidence trends are expected in early 2027, followed by an updated country profile from WHO.